Join us this March for the first ever CURE Patient-Focused Sessions, taking place at the Miami Breast Cancer Conference! 

×
To start your customized experience click the start button
Customize ?  
Start
Cancer Types
Quick Links
Award Programs
About Us
Careers
Contact Us
Newsroom
Privacy Policy
Terms & Conditions
 
Twitter
Face Book
YouTube
Instagram
 
 
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2018
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.

Lymphoma Cancer

Parameswaran Venugopal, M.D., reacts to the availability of newer novel-based therapies and the variety of treatment strategies that can be used to better manage patients with follicular lymphoma.
Gerald Koch and his oncologist, Parameswaran Venugopal, M.D., provide advice to help encourage newly diagnosed patients with follicular lymphoma to take a proactive role in managing their journey.
Insight related to the importance of coordinated care and the rationale for involving various health care professionals in the management of patients who are diagnosed with follicular lymphoma.
Jennifer L. Garson, PA-C, explains how she helps counsel and prepare patients with follicular lymphoma, like Gerald, for treatment with a PI3K targeted therapy.
Parameswaran Venugopal, M.D., explains the rationale for treating Gerald, a patient with follicular lymphoma, with PI3K targeted therapy following a relapse.
Gerald Koch and his medical oncologist, Parameswaran Venugopal, M.D., recall the types of tests used to diagnose Gerald with follicular lymphoma and explain how he was managed through early lines of therapy based on his prognosis.
Rush University Medical Center health care professionals highlight typical risk factors and considerations tied to a patient’s diagnosis of follicular lymphoma.
Brielle Benyon
Certain groups of pediatric and adolescent patients are less likely to receive fertility preservation consultation, recent research says.
LISA MACHADO
Toronto’s Jeff Lipton, PhD, MD, FRCPC, shares his thoughts on the outlook for blood cancers.
Kristie L. Kahl
In an interview with CURE, Filippo Milano, M.D., Ph.D., explains what cord blood transplantation is and why it is important for patients to learn more.
×
×

Sign In

Not a member? Sign up now!
Continue without login
Continue
×

Sign Up

Patient Caregiver Advocate Other